The AUCs were significantly higher than 0.5 for only 8 genes (p<0.05 for 2 genes and p<0.001 for 6 genes) in ER+/HER2- breast cancer patients who received taxane-based chemotherapy (Table 2). This evidence concerns the gene ERBB2 and breast cancer.